Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy - Kohles, N; Nagel, D; Jüngst, D; Stieber, P; Holdenrieder, S (Tumour Biol, 2012)